Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MAZE THERAPEUTICS, INC.(MAZE) | 0 | 4,120,053 | +4,120,053 | 0 | 45,362 | 22.00% | +45,362 |
| GOSSAMER BIO, INC.(GOSS) | 8,055,916 | 8,055,916 | 0 | 7,287 | 8,781 | 4.26% | +1,494 |
| UNITY BIOTECHNOLOGY, INC. | 1,004,817 | 1,004,817 | 0 | 981 | 1,045 | 0.51% | +64 |
| CERO THERAPEUTICS HOLDINGS, INC.(CERO) | 0 | 22,102 | +22,102 | 0 | 16 | 0.01% | +16 |
| CERO THERAPEUTICS HOLDINGS, INC.(CERO) | 9,393,561 | 0 | -9,393,561 | 564 | 0 | — | -564 |
| Q32 BIO INC.(FIXX) | 320,482 | 320,482 | 0 | 1,102 | 532 | 0.26% | -570 |
| VERVE THERAPEUTICS, INC. | 2,008,809 | 2,008,809 | 0 | 11,330 | 9,120 | 4.42% | -2,210 |
| SINGULAR GENOMICS SYSTEMS, INC. | 126,630 | 0 | -126,630 | 2,460 | 0 | — | -2,460 |
| ERASCA, INC.(ERAS) | 11,055,554 | 11,055,554 | 0 | 27,749 | 15,146 | 7.34% | -12,603 |
| BEAM THERAPEUTICS INC.(BEAM) | 4,540,132 | 4,540,132 | 0 | 112,595 | 88,669 | 43.00% | -23,926 |
| RAPPORT THERAPEUTICS, INC.(RAPP) | 3,728,738 | 3,728,738 | 0 | 66,148 | 37,548 | 18.21% | -28,599 |